2013
DOI: 10.1136/archdischild-2012-303089
|View full text |Cite
|
Sign up to set email alerts
|

Doxapram and hypokalaemia in very preterm infants: Table 1

Abstract: This retrospective study underlines the high incidence of severe hypokalaemia in very preterm infants and an increased risk of severe hypokalaemia during doxapram treatment. We recommend potassium monitoring during any use of doxapram.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
18
0
1

Year Published

2013
2013
2023
2023

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 16 publications
(19 citation statements)
references
References 22 publications
0
18
0
1
Order By: Relevance
“…Six studies reported on different short-term outcomes [20,21,22,24,25,26]. Yamazaki et al [26] showed that almost 80% of the infants treated with doxapram had a partial or complete cessation of apnea.…”
Section: Resultsmentioning
confidence: 99%
See 4 more Smart Citations
“…Six studies reported on different short-term outcomes [20,21,22,24,25,26]. Yamazaki et al [26] showed that almost 80% of the infants treated with doxapram had a partial or complete cessation of apnea.…”
Section: Resultsmentioning
confidence: 99%
“…Two studies assessed neurodevelopmental sequelae at 12-18 months' corrected age [23,24]. Fischer et al [21 ]and Czaba-Hnizdo et al [20 ]had a low risk of bias , Yamazaki et al [26], Kumita et al [25] and Prins et al [22] had a high risk of bias, the risk of bias could not be assessed for the publications in abstract form only (fig. 3).…”
Section: Resultsmentioning
confidence: 99%
See 3 more Smart Citations